Table 2.
Correlation between clinicopathologic data and HLA-II expression in the Kazakh ESCC
| Expression of HLA-II |
|||||
|---|---|---|---|---|---|
| Clinicopathologic Parameter | No. of Cases | Positive n(%) | Negative n(%) | X2 | P |
| Age (y) | |||||
| ≤ Median (53y) | 21 | 13(43.3%) | 17(56.7%) | ||
| > Median | 45 | 11(30.6%) | 25(69.4%) | 1.155 | 0.314 |
| Gender | |||||
| M | 38 | 22(57.9%) | 16(42.1%) | ||
| F | 28 | 20(71.4%) | 8(28.6%) | 1.276 | 0.308 |
| Histologic grade | |||||
| Well | 24 | 17(70.8%) | 7(29.2%） | ||
| Moderate + poor | 42 | 25(59.5%) | 17(40.5% | 0.844 | 0.431 |
| Depth of invasion | |||||
| TI-T2 | 44 | 30(68.2%) | 14(31.8%) | ||
| T3-T4 | 22 | 9(40.9%) | 13(59.1%) | 4.513 | 0.062 |
| Nodal status | |||||
| PN− | 29 | 20(69.0%) | 9(31.0%) | ||
| pN+ | 37 | 17(45.9%) | 20(54.1%) | 3.497 | 0.082 |
| TNM stage | |||||
| I-II | 34 | 23(67.6%) | 11(32.4%) | ||
| III-IV | 32 | 13(40.6%) | 19(59.4%) | 4.855 | 0.047* |
*
P < 0.05.